
Yong D. Pak
Examiner (ID: 7339, Phone: (571)272-0935 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1684 |
| Issued Applications | 984 |
| Pending Applications | 234 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19043798
[patent_doc_number] => 11932884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => High efficiency base editors comprising Gam
[patent_app_type] => utility
[patent_app_number] => 17/700109
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 38649
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700109 | High efficiency base editors comprising Gam | Mar 20, 2022 | Issued |
Array
(
[id] => 19218169
[patent_doc_number] => 20240182873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => PRENYLTRANSFERASE AND A TRANSGENIC CELL, TISSUE, AND ORGANISM COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 18/281536
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18281536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/281536 | PRENYLTRANSFERASE AND A TRANSGENIC CELL, TISSUE, AND ORGANISM COMPRISING SAME | Mar 9, 2022 | Pending |
Array
(
[id] => 17720738
[patent_doc_number] => 20220213458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => MAD NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 17/691018
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691018 | MAD NUCLEASES | Mar 8, 2022 | Pending |
Array
(
[id] => 19076685
[patent_doc_number] => 11946036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Bacterium and obtaining method and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/671001
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 12813
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/671001 | Bacterium and obtaining method and application thereof | Feb 13, 2022 | Issued |
Array
(
[id] => 17627565
[patent_doc_number] => 20220162580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ENGINEERED DEOXYRIBOSE-PHOSPHATE ALDOLASES
[patent_app_type] => utility
[patent_app_number] => 17/592869
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592869 | Engineered deoxyribose-phosphate aldolases | Feb 3, 2022 | Issued |
Array
(
[id] => 18077743
[patent_doc_number] => 20220403355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => CELL-FREE PRODUCTION OF RIBONUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/591514
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591514 | CELL-FREE PRODUCTION OF RIBONUCLEIC ACID | Feb 1, 2022 | Abandoned |
Array
(
[id] => 17960359
[patent_doc_number] => 20220340939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => HETEROLOGOUS PRODUCTION OF 10-METHYLSTEARIC ACID BY CELLS EXPRESSING RECOMBINANT METHYLTRANSFERASE
[patent_app_type] => utility
[patent_app_number] => 17/649365
[patent_app_country] => US
[patent_app_date] => 2022-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17649365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/649365 | HETEROLOGOUS PRODUCTION OF 10-METHYLSTEARIC ACID BY CELLS EXPRESSING RECOMBINANT METHYLTRANSFERASE | Jan 29, 2022 | Abandoned |
Array
(
[id] => 17595699
[patent_doc_number] => 20220145273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => LIPASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
[patent_app_type] => utility
[patent_app_number] => 17/583269
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583269
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583269 | LIPASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | Jan 24, 2022 | Pending |
Array
(
[id] => 17579100
[patent_doc_number] => 20220135955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Reverse Transcriptase Mutants with Increased Activity and Thermostability
[patent_app_type] => utility
[patent_app_number] => 17/578275
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578275 | Reverse transcriptase mutants with increased activity and thermostability | Jan 17, 2022 | Issued |
Array
(
[id] => 17611883
[patent_doc_number] => 20220154162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => VARIANTS OF CHYMOSIN WITH IMPROVED MILK-CLOTTING PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/571413
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571413 | Variants of chymosin with improved milk-clotting properties | Jan 6, 2022 | Issued |
Array
(
[id] => 19800823
[patent_doc_number] => 20250066748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => HELICASE BCH2X AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/723633
[patent_app_country] => US
[patent_app_date] => 2021-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18723633
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/723633 | HELICASE BCH2X AND USE THEREOF | Dec 30, 2021 | Pending |
Array
(
[id] => 19374126
[patent_doc_number] => 12065676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Photosystem I-hydrogenase chimeras for hydrogen production
[patent_app_type] => utility
[patent_app_number] => 17/565684
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 38
[patent_no_of_words] => 24674
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/565684 | Photosystem I-hydrogenase chimeras for hydrogen production | Dec 29, 2021 | Issued |
Array
(
[id] => 17671022
[patent_doc_number] => 20220184189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR SAFE AND EFFECTIVE THROMBOLYSIS USING SEQUENTIAL ADMINISTRATION OF TISSUE PLASMINOGEN ACTIVATOR AND MUTANT PRO-UROKINASE
[patent_app_type] => utility
[patent_app_number] => 17/566077
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17566077
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/566077 | Methods for safe and effective thrombolysis using sequential administration of tissue plasminogen activator and mutant pro-urokinase | Dec 29, 2021 | Issued |
Array
(
[id] => 17548442
[patent_doc_number] => 20220119783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => RECOMBINANT HOST CELLS FOR THE PRODUCTION OF MALONATE
[patent_app_type] => utility
[patent_app_number] => 17/646437
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17646437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/646437 | RECOMBINANT HOST CELLS FOR THE PRODUCTION OF MALONATE | Dec 28, 2021 | Abandoned |
Array
(
[id] => 17533924
[patent_doc_number] => 20220112533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => METHOD FOR PRODUCING GALACTOOLIGOSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 17/559121
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559121 | Method for producing galactooligosaccharide | Dec 21, 2021 | Issued |
Array
(
[id] => 19536953
[patent_doc_number] => 12129494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => T7 RNA polymerase variants
[patent_app_type] => utility
[patent_app_number] => 17/558454
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20001
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558454 | T7 RNA polymerase variants | Dec 20, 2021 | Issued |
Array
(
[id] => 19181240
[patent_doc_number] => 11987824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Additional endoglucanase variants and methods
[patent_app_type] => utility
[patent_app_number] => 17/556504
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 30265
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556504 | Additional endoglucanase variants and methods | Dec 19, 2021 | Issued |
Array
(
[id] => 17688108
[patent_doc_number] => 20220195400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => ENGINEERED URIDINE PHOSPHORYLASE VARIANT ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/555012
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555012 | Engineered uridine phosphorylase variant enzymes | Dec 16, 2021 | Issued |
Array
(
[id] => 19067634
[patent_doc_number] => 20240102060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => ENZYMES AND METHODS FOR FERMENTATIVE PRODUCTION OF MONOTERPENE ESTERS
[patent_app_type] => utility
[patent_app_number] => 18/267491
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267491
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267491 | ENZYMES AND METHODS FOR FERMENTATIVE PRODUCTION OF MONOTERPENE ESTERS | Dec 16, 2021 | Pending |
Array
(
[id] => 19067172
[patent_doc_number] => 20240101598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => METHODS FOR THE PURIFICATION OF REFOLDED FC-PEPTIDE FUSION PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/039688
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039688
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039688 | Methods for the purification of refolded Fc-peptide fusion protein | Dec 16, 2021 | Issued |